Trial intelligence / Profile preview

FMT for Constipation with Difficult Defecation

NCT03308461Completed

Sponsor
The Second Affiliated Hospital of Nanjing Medical University
Start
May 2013
Primary completion
May 2017
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Open-label trial of fecal microbiome transplant in constipation, sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: Defecation frequency at 12 weeks and Stool consistency at 12 weeks. Started May 2013; status: completed.

02

Drugs

fecal microbiome transplant
03

Conditions

constipation

Beyond the preview

Go deeper on NCT03308461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03308461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call